{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T14:07:35Z","timestamp":1772806055312,"version":"3.50.1"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81300315"],"award-info":[{"award-number":["81300315"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1016\/j.ejphar.2016.06.032","type":"journal-article","created":{"date-parts":[[2016,6,27]],"date-time":"2016-06-27T21:38:41Z","timestamp":1467063521000},"page":"218-225","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"special_numbering":"C","title":["GHSR-1a is a novel pro-angiogenic and anti-remodeling target in rats after myocardial infarction"],"prefix":"10.1016","volume":"788","author":[{"given":"Ming-Jie","family":"Yuan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bin","family":"Kong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cong-Xin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danny","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2016.06.032_bib1","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.114.001464","article-title":"Growth hormone-releasing hormone agonists reduce myocardial infarct scar in swine with subacute ischemic cardiomyopathy","volume":"4","author":"Bagno","year":"2015","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.ejphar.2016.06.032_bib2","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1016\/j.peptides.2010.08.019","article-title":"Altered myocardial expression of ghrelin and its receptor (GHSR-1a) in patients with severe heart failure","volume":"31","author":"Beiras-Fernandez","year":"2010","journal-title":"Peptides"},{"key":"10.1016\/j.ejphar.2016.06.032_bib3","doi-asserted-by":"crossref","first-page":"20452","DOI":"10.1073\/pnas.0811680106","article-title":"Growth hormone-releasing hormone as an agonist of the ghrelin receptor GHS-R1a","volume":"105","author":"Casanueva","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ejphar.2016.06.032_bib4","first-page":"395","article-title":"Potential mechanism for endothelial progenitor cell therapy in acute myocardial infarction: activation of VEGF- PI3K\/Akte-NOS pathway","volume":"43","author":"Cheng","year":"2013","journal-title":"Ann. Clin. Lab. Sci."},{"key":"10.1016\/j.ejphar.2016.06.032_bib5","doi-asserted-by":"crossref","first-page":"4779","DOI":"10.2174\/138161212803216951","article-title":"The use of ghrelin and ghrelin receptor agonists as a treatment for animal models of disease: efficacy and mechanism","volume":"18","author":"DeBoer","year":"2012","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.ejphar.2016.06.032_bib6","doi-asserted-by":"crossref","first-page":"518909","DOI":"10.1155\/2013\/518909","article-title":"Structure and physiological actions of ghrelin","volume":"2013","author":"Delporte","year":"2013","journal-title":"Scientifica"},{"key":"10.1016\/j.ejphar.2016.06.032_bib7","doi-asserted-by":"crossref","first-page":"17260","DOI":"10.1073\/pnas.1420375111","article-title":"Agonists of growth hormone-releasing hormone stimulate self-renewal of cardiac stem cells and promote their survival","volume":"111","author":"Florea","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ejphar.2016.06.032_bib8","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1038\/gt.2012.17","article-title":"VEGF gene therapy: therapeutic angiogenesis in the clinic and beyond","volume":"19","author":"Giacca","year":"2012","journal-title":"Gene Ther."},{"key":"10.1016\/j.ejphar.2016.06.032_bib9","doi-asserted-by":"crossref","first-page":"2286","DOI":"10.1016\/j.peptides.2009.09.004","article-title":"Ghrelin inhibits post-infarct myocardial remodeling and improves cardiac function through anti-inflammation effect","volume":"30","author":"Huang","year":"2009","journal-title":"Peptides"},{"key":"10.1016\/j.ejphar.2016.06.032_bib10","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1093\/eurheartj\/ehu505","article-title":"Cardiovascular risk in post-myocardial infarction patients: nationwide real world data demonstrate the importance of a long-term perspective","volume":"36","author":"Jernberg","year":"2015","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ejphar.2016.06.032_bib11","doi-asserted-by":"crossref","first-page":"9728","DOI":"10.18632\/oncotarget.3303","article-title":"New therapeutic approach to heart failure due to myocardial infarction based on targeting growth hormone-releasing hormone receptor","volume":"6","author":"Kanashiro-Takeuchi","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.ejphar.2016.06.032_bib12","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1073\/pnas.1119203109","article-title":"Activation of growth hormone releasing hormone (GHRH) receptor stimulates cardiac reverse remodeling after myocardial infarction (MI)","volume":"109","author":"Kanashiro-Takeuchi","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ejphar.2016.06.032_bib13","doi-asserted-by":"crossref","first-page":"e0126697","DOI":"10.1371\/journal.pone.0126697","article-title":"Effect of ghrelin on mortality and cardiovascular outcomes in experimental rat and mice models of heart failure: a systematic review and meta-analysis","volume":"10","author":"Khatib","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.ejphar.2016.06.032_bib14","doi-asserted-by":"crossref","first-page":"74","DOI":"10.4103\/1995-705X.144792","article-title":"Cardioprotective effects of ghrelin in heart failure: from gut to heart","volume":"15","author":"Khatib","year":"2014","journal-title":"Heart Views"},{"key":"10.1016\/j.ejphar.2016.06.032_bib15","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1038\/45230","article-title":"Ghrelin is a growth-hormone-releasing acylated peptide from stomach","volume":"402","author":"Kojima","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2016.06.032_bib16","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.peptides.2012.02.025","article-title":"Ghrelin signaling in heart remodeling of adult obese mice","volume":"35","author":"Lacerda-Miranda","year":"2012","journal-title":"Peptides"},{"key":"10.1016\/j.ejphar.2016.06.032_bib17","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.ijcard.2014.11.006","article-title":"The cellular immune system in the post-myocardial infarction repair process","volume":"179","author":"Latet","year":"2015","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ejphar.2016.06.032_bib18","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.abb.2014.06.023","article-title":"AMPK inhibits cardiac hypertrophy by promoting autophagy via mTORC1","volume":"558","author":"Li","year":"2014","journal-title":"Arch. Biochem Biophys."},{"key":"10.1016\/j.ejphar.2016.06.032_bib19","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1161\/HYPERTENSIONAHA.114.03726","article-title":"Ghrelin as a treatment for cardiovascular diseases","volume":"64","author":"Mao","year":"2014","journal-title":"Hypertension"},{"key":"10.1016\/j.ejphar.2016.06.032_bib20","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/j.jacc.2015.05.053","article-title":"Duration of dual antiplatelet therapy after coronary stenting: a review of the evidence","volume":"66","author":"Montalescot","year":"2015","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ejphar.2016.06.032_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.vph.2015.08.005","article-title":"Apelinergic system in endothelial cells and its role in angiogenesis in myocardial ischemia","volume":"76","author":"Novakova","year":"2016","journal-title":"Vasc. Pharm."},{"key":"10.1016\/j.ejphar.2016.06.032_bib22","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1097\/MCO.0b013e328365b9be","article-title":"Ghrelin: much more than a hunger hormone","volume":"16","author":"Pradhan","year":"2013","journal-title":"Curr. Opin. Clin. Nutr. Metab. Care"},{"key":"10.1016\/j.ejphar.2016.06.032_bib23","doi-asserted-by":"crossref","first-page":"7388","DOI":"10.1038\/ncomms8388","article-title":"AAV-mediated in vivo functional selection of tissue-protective factors against ischaemia","volume":"6","author":"Ruozi","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejphar.2016.06.032_bib24","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1093\/eurheartj\/ehv500","article-title":"Everolimus-eluting bioresorbable stent vs. durable polymer everolimus-eluting metallic stent in patients with ST-segment elevation myocardial infarction: results of the randomized ABSORB ST-segment elevation myocardial infarction-TROFI II trial","volume":"37","author":"Sabate","year":"2016","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ejphar.2016.06.032_bib25","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1055\/s-0035-1559758","article-title":"Effects of Intracerebroventricularly (ICV) injected ghrelin on cardiac inducible nitric oxide synthase activity\/expression in obese rats","volume":"123","author":"Sudar Milovanovic","year":"2015","journal-title":"Exp. Clin. Endocrinol. Diabetes"},{"key":"10.1016\/j.ejphar.2016.06.032_bib26","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1161\/CIRCRESAHA.116.305097","article-title":"Cellular origin and developmental program of coronary angiogenesis","volume":"116","author":"Tian","year":"2015","journal-title":"Circ. Res."},{"key":"10.1016\/j.ejphar.2016.06.032_bib27","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1159\/000360593","article-title":"Ghrelin and the cardiovascular system","volume":"43","author":"Tokudome","year":"2014","journal-title":"Front Horm. Res."},{"key":"10.1016\/j.ejphar.2016.06.032_bib28","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.peptides.2015.09.004","article-title":"Ghrelin ameliorates impaired angiogenesis of ischemic myocardium through GHSR1a-mediated AMPK\/eNOS signal pathway in diabetic rats","volume":"73","author":"Wang","year":"2015","journal-title":"Peptides"},{"key":"10.1016\/j.ejphar.2016.06.032_bib29","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.bcp.2014.01.040","article-title":"Ghrelin inhibits doxorubicin cardiotoxicity by inhibiting excessive autophagy through AMPK and p38-MAPK","volume":"88","author":"Wang","year":"2014","journal-title":"Biochem Pharm."},{"key":"10.1016\/j.ejphar.2016.06.032_bib30","doi-asserted-by":"crossref","first-page":"4837","DOI":"10.3390\/ijms15034837","article-title":"The growth hormone secretagogue receptor: its intracellular signaling and regulation","volume":"15","author":"Yin","year":"2014","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2016.06.032_bib31","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.regpep.2012.08.013","article-title":"Myocardial angiogenesis after chronic ghrelin treatment in a rat myocardial infarction model","volume":"179","author":"Yuan","year":"2012","journal-title":"Regul. Pept."},{"key":"10.1016\/j.ejphar.2016.06.032_bib32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.regpep.2014.07.001","article-title":"Expression of ghrelin and its receptor in rats after coronary artery ligation","volume":"192\u2013193","author":"Yuan","year":"2014","journal-title":"Regul. Pept."},{"key":"10.1016\/j.ejphar.2016.06.032_bib33","first-page":"1770","article-title":"AMPK activity is down-regulated in endothelial cells of GHS-R(-\/-) mice","volume":"6","author":"Zhang","year":"2013","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"10.1016\/j.ejphar.2016.06.032_bib34","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1007\/s00432-011-1049-2","article-title":"PI3K\/Akt and MAPK\/ERK1\/2 signaling pathways are involved in IGF-1-induced VEGF-C upregulation in breast cancer","volume":"137","author":"Zhu","year":"2011","journal-title":"J. Cancer Res. Clin. Oncol."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299916303910?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299916303910?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,2]],"date-time":"2022-07-02T04:32:33Z","timestamp":1656736353000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299916303910"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":34,"alternative-id":["S0014299916303910"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2016.06.032","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2016,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"GHSR-1a is a novel pro-angiogenic and anti-remodeling target in rats after myocardial infarction","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2016.06.032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}